Skip to main content

LGL PARTNERS, LLC

Location
PHILADELPHIA, PA
Portfolio Value
Micro $88,023,646
Diversification
Highly concentrated
Filing Date
Global Rank
#5,608 / 8,232 ▲ 299
Top Industry
Drug Manufacturers - General 10.9%
3Y Alpha vs SPY
0.0%
Period ended 2 months ago
Filed May 14, 2026 · 30d
25 quarters · since Mar 2020

Clone Performance

Jun 2023–Jun 2026 · vs SPY

Hypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.

Cloned portfolio
+77.4%
SPY
+76.5%
Annualised alpha
+0.2%
Max drawdown
−19.8%

Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.

Portfolio Concentration

27 positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025
Top Position
72.6%
−3.9 pts
Top 5
89.9%
−4.9 pts
Top 10
94.1%
−3.9 pts
HHI
5,463
Jun 2023 → Mar 2026 · range 1,962 – 6,248
Highly concentrated−628

Portfolio Trend

25 quarters · across all stocks

Sector Breakdown

As of Mar 31, 2026
Sector % Portfolio Value
Unclassified 87.6% $77,144,851
Healthcare 3.8% $3,312,935
Consumer Cyclical 2.3% $1,981,272
Technology 2.1% $1,891,515
Industrials 1.4% $1,210,283
Real Estate 1.1% $964,288
Financial Services 1.0% $858,988
Energy 0.3% $241,160
Basic Materials 0.2% $217,638
Communication Services 0.2% $200,716

Last Quarter's Activity

Export CSV
Mar 31, 2026 vs Dec 31, 2025

Added To

Positions the filer increased
9 positions
Ticker Δ Shares Shares Value Open

Trimmed

Positions the filer reduced
2 positions
Ticker Δ Shares Shares Value Open

New Positions

Positions the filer opened this quarter
10 positions
Ticker Shares Value Open

Sold Out

Positions the filer fully exited
No qualifying positions this quarter.

Portfolio Positions

Export CSV View 13F filing
27 positions · $88,023,646 total · as of Mar 31, 2026
Ticker Company Shares Value (USD) % of Portfolio History